Skip to main content
Molecular Neurodegeneration logoLink to Molecular Neurodegeneration
. 2015 Oct 23;10:54. doi: 10.1186/s13024-015-0051-6

Erratum to: Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression

Xi Chen 1,3, Hannah V McCue 1, Shi Quan Wong 1, Sudhanva S Kashyap 1, Brian C Kraemer 2, Jeff W Barclay 1, Robert D Burgoyne 1, Alan Morgan 1,
PMCID: PMC4619536  PMID: 26496836

The original version of this article [1] unfortunately contained a mistake. The author list contained a spelling error for the author Hannah V. McCue. The original article has been corrected for this error. The corrected author list is given below:

Xi Chen, Hannah V. McCue, Shi Quan Wong, Sudhanva S. Kashyap, Brian C. Kraemer, Jeff W. Barclay, Robert D. Burgoyne and Alan Morgan

Footnotes

The online version of the original article can be found under doi:10.1186/s13024-015-0046-3.

Reference

  • 1.Chen X, McCue HV, Wong SQ, Kashyap SS, Kraemer BC, Barclay JW, et al. Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression. Mol Neurodegener. 2015;10:51. doi: 10.1186/s13024-015-0046-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Neurodegeneration are provided here courtesy of BMC

RESOURCES